<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 12 )*
------
Del Laboratories, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $1.00 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
24509110309
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
page 1 of 3 pages
<PAGE>
CUSIP No. 24509110309 13G Page 2 of 3 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
Martin E. Revson
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER (a) / /
OF A GROUP* (b) / /
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- -------------------------------------------------------------------------------
NUMBER OF SHARES (5) SOLE VOTING
BENEFICIALLY POWER
OWNED BY 710,506
EACH REPORTING --------------------------------------------------
PERSON WITH (6) SHARED VOTING
POWER
--------------------------------------------------
(7) SOLE DISPOSITIVE
POWER
710,506
--------------------------------------------------
(8) SHARED DISPOSITIVE
POWER
0
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
710,506
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
17.0 %
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
page 2 of 3 pages
<PAGE>
ITEM 4. OWNERSHIP.
(a) AMOUNT BENEFICIALLY OWNED:
710,506 SHARES(1)
(b) PERCENT OF CLASS:
17.0%(2)
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) SOLE POWER TO VOTE OR TO DIRECT THE VOTE:
710,506
(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE:
-0-
(iii) SOLE POWER TO DISPOSE OR DIRECT THE DISPOSITION OF:
710,506
(iv) SHARED POWER TO DISPOSE OR DIRECT THE DISPOSITION
OF:
-0-
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 6 , 1996 /s/ Martin E. Revson
--- -------------------------
Martin E. Revson
- --------------------------
(1) All share numbers reported in this form reflect a 2-for-1 stock split
effected by the Issuer in June 1995.
(2) Based on 4,177,990 shares outstanding at December 31, 1995.
page 3 of 3 pages